Akèy › Maladi kadyovaskilè › North Carolina

Etid klinik pou Maladi kadyovaskilè nan North Carolina

30 etid pou Maladi kadyovaskilè ap chèche patisipan nan sit nan North Carolina.

Vil nan North Carolina

Tèks ofisyèl etid la (Anglè)

ELEVATE-HFpEF Clinical Study

Duke University Medical Center, Durham

Ap rekrite

Laj 40 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT06678841

CARE-CP (Testing a Cardiovascular Ambulatory Rapid Evaluation for Patients With Chest Pain)

Carolinas Medical Center, Charlotte
Wake Forest University Health Sciences, Winston-Salem

Ap rekrite

Laj 21 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT05897632

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

Cary Cardiology, Cary
The University of North Carolina at Chapel Hill, Chapel Hill
Physicians East, PA, Greenville
ak 5 plis

Ap rekriteFaz 3

Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07064473

Safety and Effectiveness of the Sphere-9™ Catheter and Affera™ Ablation System for the Treatment of Ventricular Tachycardia (Sphere VT)

Atrium Health Wake Forest Baptist Medical Center, Winston-Salem

Ap rekrite

Laj 18 a 85 · Tout sèks · Mizajou Sep 29, 2026 · NCT07585968

Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention

Asheville Cardiology Associates Research Department, Asheville
Novant Health Clinical Research/Heart & Vascular Institute, Charlotte
Mecklenburg Heart Specialists, Charlotte
ak 6 plis

Ap rekriteFaz 4

Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT06909565

Product Surveillance Registry

Chapel Hill
Charleston
Durham
ak 3 plis

Ap rekriteEtid obsèvasyon

Tout laj · Tout sèks · Mizajou Sep 18, 2026 · NCT01524276

Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease

Clinical Trial Site, Durham
Clinical Trial Site, Greenville
Clinical Trial Site, High Point
ak 5 plis

Ap rekriteFaz 3

Laj 18 ak plis · Tout sèks · Mizajou Sep 18, 2026 · NCT07181109

Pharmacologic Therapies to Mitigate Radiation- Associated Heart Disease

Lineberger Comprehensive Cancer Center at University of North Carolina, Chapel Hill, Chapel Hill

Ap rekriteFaz 2

Laj 18 ak plis · Tout sèks · Mizajou Sep 17, 2026 · NCT07685938

Zenith® Fenestrated+ Clinical Study

University of North Carolina at Chapel Hill, Chapel Hill

Ap rekrite

Laj 18 ak plis · Tout sèks · Mizajou Sep 17, 2026 · NCT04875429

Observational Pharmaco-Epidemiology Research & Analysis

Epividian, Durham

Ap rekriteEtid obsèvasyonVolontè an sante akeyi

Laj 0 ak plis · Tout sèks · Mizajou Sep 11, 2026 · NCT03813862

Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure

Duke University, Durham

Ap rekrite

Laj 18 a 100 · Tout sèks · Mizajou Sep 9, 2026 · NCT06310031

An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)

Novant Health Heart Vas Inst, Charlotte
Medication Management LLC, Greensboro
Accellacare US Inc, Raleigh
ak 2 plis

Ap rekriteFaz 3

Laj 18 a 100 · Tout sèks · Mizajou Sep 4, 2026 · NCT07517263

A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD

Clinical Research Site, Greensboro

Ap rekriteFaz 2

Laj 18 a 85 · Tout sèks · Mizajou Sep 2, 2026 · NCT07333183

Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults

Asheville VA-Charles George VA Medical Center, Asheville
University of North Carolina, Chapel Hill
Atrium Health, Charlotte
ak 5 plis

Ap rekriteFaz 4Volontè an sante akeyi

Laj 75 ak plis · Tout sèks · Mizajou Sep 1, 2026 · NCT04262206

Cardiovascular Effects of Very Low Nicotine Content Cigarettes

Wake Forest University Health Sciences, Winston-Salem

Ap rekriteFaz 1 bonèVolontè an sante akeyi

Laj 21 ak plis · Tout sèks · Mizajou Aug 28, 2026 · NCT05707871

A Study About How Blood Cell Growth Patterns Relate to Heart Health After Treatment for Hodgkin Lymphoma

Wake Forest University Health Sciences, Winston-Salem

Ap rekriteEtid obsèvasyon

Laj 7 ak plis · Tout sèks · Mizajou Aug 25, 2026 · NCT05705531

A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event

Research Site, Asheville
Research Site, Chapel Hill
Research Site, Charlotte
ak 11 plis

Ap rekriteFaz 3

Laj 18 ak plis · Tout sèks · Mizajou Aug 24, 2026 · NCT07000357

OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events

Duke University Health System, Durham
Moses H Cone Memorial Hospital, Greensboro
Medication Management LLC, Greensboro
ak 6 plis

Ap rekriteFaz 3

Laj 50 a 105 · Tout sèks · Mizajou Aug 21, 2026 · NCT07136012

Global Paradise System US Post Approval Study

University of North Carolina at Chapel Hill School of Medicine, Chapel Hill
Durham VA Health System, Durham

Ap rekriteEtid obsèvasyon

Laj 18 ak plis · Tout sèks · Mizajou Aug 12, 2026 · NCT06297291

Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Established ASCVD

Wake Forest University Baptist Medical Center, Winston-Salem

Ap rekriteFaz 3

Laj 18 a 80 · Tout sèks · Mizajou Aug 7, 2026 · NCT06813911

PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III

UNC Medical Center, Durham
Duke University, Durham

Ap rekrite

Laj 18 ak plis · Tout sèks · Mizajou Jun 29, 2026 · NCT05934487

SPYRAL GEMINI Pilot Study

University of North Carolina (UNC) Memorial Hospital, Chapel Hill

Ap rekrite

Laj 18 a 80 · Tout sèks · Mizajou Jun 24, 2026 · NCT06907147

Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure

University of North Carolina at Chapel Hill, Chapel Hill
Carolinas Medical Center, Charlotte

Ap rekrite

Laj 18 ak plis · Tout sèks · Mizajou Jun 10, 2026 · NCT06526195

Sequential Multiple Assignment Randomized Trial to Reduce Food Insecurity

Wake Forest University Health Sciences, Winston-Salem

Ap rekrite

Laj 18 ak plis · Tout sèks · Mizajou May 6, 2026 · NCT07031739

Emergency Medicine Cardiovascular Risk Assessment for Lipid Disorders Trial

Wake Forest University Health Sciences, Winston-Salem

Ap rekriteFaz 2

Laj 40 a 75 · Tout sèks · Mizajou Feb 27, 2026 · NCT06488105

PKP2-ACM Natural History Study

Duke University, Durham

Ap rekriteEtid obsèvasyon

Laj 12 ak plis · Tout sèks · Mizajou Feb 27, 2026 · NCT06644742

Beta-Blocker Influences on Inflammatory and Neural Responses to Stress

Social Neuroscience and Health Laboratory, Chapel Hill

Ap rekriteFaz 4Volontè an sante akeyi

Laj 18 a 30 · Tout sèks · Mizajou Oct 29, 2025 · NCT06263452

MagicTouch™Sirolimus-Coated Balloon for Treatment of Coronary Artery Lesions in Small Vessels

NC Heart and Vascular Research, LLC, Raleigh

Ap rekrite

Laj 18 a 80 · Tout sèks · Mizajou Sep 11, 2025 · NCT06271590

MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions

NC Heart and Vascular Research, LLC, Raleigh

Ap rekrite

Laj 18 a 110 · Tout sèks · Mizajou Feb 25, 2025 · NCT05908331

Multi-Center Study of Clinical and Inflammatory Outcomes in Intensive Cardiac Rehabilitation and Traditional Cardiac Rehabilitation Programs

Mission Health, Asheville

Ap rekrite

Laj 18 ak plis · Tout sèks · Mizajou May 21, 2024 · NCT06424119

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.